Bluejay Diagnostics Inc

NASDAQ:BJDXUnited States

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a near-patient testing system for triage and monitoring of disease progression. The Company's Symphony platform is a technology platform that provides measurements of key diagnostic biomarkers found in whole blood. The Symphony analyzer orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The Company's first product candidate, an IL-6 test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices (IVDs) market, including sepsis, cardio-metabolic diseases, cancer, and other diseases that require rapid tests.

Contact Information

Headquarters

360 Massachusetts Avenue, Suite 203ACTON, MA, United States 01720

Phone

978-631-0152

Fax

302-636-5454

Executives

Independent Chairman of the Board

Douglas Wurth

President, Chief Executive Officer, Co-Founder, Director

Neil Dey

Chief Financial Officer

Kenneth Fisher

Chief Technology Officer

Jason Cook

Director

Svetlana Dey